Literature DB >> 12077439

Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase.

Patricia A Elkins1, Yen Sen Ho, Ward W Smith, Cheryl A Janson, Karla J D'Alessio, Michael S McQueney, Maxwell D Cummings, Anne M Romanic.   

Abstract

The X-ray crystal structure of the proform of human matrix metalloproteinase MMP9 has been solved to 2.5 A resolution. The construct includes the prodomain, the catalytic domain and three FnII (fibronectin type II) domains. The prodomain is inserted into the active-site cleft, blocking access to the catalytic zinc. Comparison with the crystal structure of the most closely related MMP, MMP2, indicates that the conformations of residues in the active-site cleft and in the cysteine-switch peptide of the prodomain are highly conserved and that design of MMP9-specific inhibitors will be challenging. In common with MMP2, the MMP9 S1' inhibitor-binding pocket is large compared with that of other MMPs. One small point of difference in the S1' binding pockets of MMP9 and MMP2 may provide an opportunity to explore the design of specific inhibitors. The side chain of Arg424 in MMP9 is angled slightly away from the S1' pocket when compared with the corresponding residue in MMP2, Thr424. The secondary structure of the FnII domains is conserved between the two closely related MMPs, although the second FnII domain makes no contact with the catalytic domain in MMP9, while the same domain in MMP2 has a substantial area of interaction with the catalytic domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077439     DOI: 10.1107/s0907444902007849

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  39 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

Review 2.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

3.  Proenzyme structure and activation of astacin metallopeptidase.

Authors:  Tibisay Guevara; Irene Yiallouros; Reinhild Kappelhoff; Steffen Bissdorf; Walter Stöcker; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

4.  Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.

Authors:  Ping Pei; Michael P Horan; Russ Hille; Craig F Hemann; Steven P Schwendeman; Susan R Mallery
Journal:  Free Radic Biol Med       Date:  2006-07-15       Impact factor: 7.376

5.  Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential.

Authors:  Netta Sela-Passwell; Raghavendra Kikkeri; Orly Dym; Haim Rozenberg; Raanan Margalit; Rina Arad-Yellin; Miriam Eisenstein; Ori Brenner; Tsipi Shoham; Tamar Danon; Abraham Shanzer; Irit Sagi
Journal:  Nat Med       Date:  2011-12-25       Impact factor: 53.440

6.  Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.

Authors:  Robert H Scannevin; Richard Alexander; Tara Mezzasalma Haarlander; Sharon L Burke; Monica Singer; Cuifen Huo; Yue-Mei Zhang; Diane Maguire; John Spurlino; Ingrid Deckman; Karen I Carroll; Frank Lewandowski; Eric Devine; Keli Dzordzorme; Brett Tounge; Cindy Milligan; Shariff Bayoumy; Robyn Williams; Celine Schalk-Hihi; Kristi Leonard; Paul Jackson; Matthew Todd; Lawrence C Kuo; Kenneth J Rhodes
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

7.  Broad regulation of matrix and adhesion molecules in THP-1 human macrophages by nitroglycerin.

Authors:  Anu Shilpa Krishnatry; Daniel A Brazeau; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2009-10-15       Impact factor: 4.427

8.  Direct visualization of protease action on collagen triple helical structure.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; Arkady Bitler; David D Brand; Ghislain Opdenakker; Irit Sagi
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

9.  MMP-12 catalytic domain recognizes triple helical peptide models of collagen V with exosites and high activity.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Janelle L Lauer-Fields; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

10.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.